How much revenue does Immage Biotherapeutics make?

Immage Biotherapeutics reported $0 in revenue for fiscal year 2016. In Q2 2017 revenue was $0.

What companies are similar to Immage Biotherapeutics?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Arev Life Sciences Global Corp. (AREVF), Regenicin, Inc. (RGIN), Aeolus Pharmaceuticals, Inc. (AOLS), Halo Collective Inc. (HCANF).

Immage Biotherapeutics Corp. (IMMG) Stock

About Immage Biotherapeutics Corp.

Immage Biotherapeutics Corp. does not have significant business operations. Previously, it was engaged in developing novel immunotherapy biologics to treat various cancers in the United States. The company was formerly known as Epicure Charcoal, Inc. and changed its name to Immage Biotherapeutics Corp. in June 2015. The company was founded in 2012 and is headquartered in Bethesda, Maryland. Immage...

At a glance

Immage Biotherapeutics reported revenue of $0 for fiscal year 2016, and net income of -$216,476. In Q2 2017 (the quarter ended February 28, 2017) revenue was $0.

Figures from company filings; latest fiscal year ended August 31, 2016.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.